The Effects of the Antineoplastic Agents Used for the Treatment of Non-Head and Neck Tumors on the Teeth Development in Children

Yıl 2020, Ağız Kanserleri Özel Sayısı, 43 - 49, 28.09.2020

Sinan Horasan

https://doi.org/10.20515/otd.769867

Öz

The aim of the present study is to examine the effects of the antineoplastic agents used for the treatment of non-head and neck tumors on the tooth and jaw development in children. This study has been carried out on 30 patients whose ages were between 3 and 14. The subjects had no systemic conditions and they were receiving chemotherapy for tumors that were localized other than the head and neck region. Periapical and panoramic imaging were done before the treatment, after the treatment and at the end of the 12 months in order to examine the effects of the chemotherapeutic agents on the tooth and jaw development. Delayed eruption, root agenesis, thinning of the roots, delayed apexification and delayed physiologic root resorption were observed in the subjects. The duration of the chemotherapy and the type of neoplasm did not have any effect on the developmental complications. The antineoplastic agents used for the treatment of non-head and neck tumors in children may have negative late effects on the tooth and root development.

Anahtar Kelimeler

tooth development; jaw development; antineoplastic agent; tumor; child

Çocuklarda Baş-Boyun Bölgesi Haricinde Oluşan Tümörlerin Tedavisinde Kullanılan Antineoplastik Ajanların Diş Gelişimi Üzerindeki Etkileri

Öz

Bu çalışmanın amacı; çocukluk çağı tümörlerinde baş-boyun bölgesi haricinde oluşan neoplazmaların tedavisinde kullanılan antineoplastik ajanların diş ve çene gelişimine etkisini araştırmaktır. Bu çalışma, tümör lokalizasyonu baş-boyun bölgesi dışında oluşan, yaşları 3 ve 14 arasında değişen, kemoterapi uygulanan ve başka bir sistemik hastalığı olmayan 30 hasta üzerinde yapılmıştır. Bu hastalardan tedavinin başlangıcında, tedavinin sonunda ve tedavi bitiminden 12 ay sonra periapikal ve panoramik radyografiler çekilerek diş ve diş köklerinin uygulanan kemoterapötik ajanlardan etkilenip etkilenmediği incelenmiştir. Hastalarda sürmede gecikme, kök agenezi, kökte incelme, apeksifikasyonda gecikme ve fizyolojik kök rezorpsiyonunda gecikme görülmüştür. Uygulanan kemoterapinin süresinin ve neoplazmların tiplerinin oluşan komplikasyonlar üzerinde bir etkisi olmadığı belirlenmiştir. Çocuklarda baş-boyun bölgesi dışında kalan kanserlerin tedavisinde kullanılan antineoplastik ajanların geç dönemde diş ve kök gelişimi üzerinde olumsuz etkileri görülebilir.

Anahtar Kelimeler

diş gelişimi, çene gelişimi, antineoplastik ajan, tümör, çocuk

Kaynakça

• 1.Fayle SA, Curzon ME. Oral complications in pediatric oncology patients. Pediatr Dent. 1991;13:289-95.
• 2.Simon AR, Roberts MW. Management of oral complications associated with cancer therapy in pediatric patients. ASDC J Dent Child. 1991;58(5):384-9.
• 3.Krywulak ML. Dental considerations for the pediatric oncology patient. J Can Dent Assoc. 1992;58:125, 7-30.
• 4.Naylor GD, Terezhalmy GT. Oral complications of cancer chemotherapy: prevention and management. Spec Care Dentist. 1988;8:150-6.
• 5.Pajari U, Lanning M, Larmas M. Prevalence and location of enamel opacities in children after anti-neoplastic therapy. Community Dent Oral Epidemiol. 1988;16:222-6.
• 6.Cevik N. 9. Pediatrik tümörler ve tıpta yenilikler kongre raporu, Türkiye çocukluk kanser vakaları. Ankara (özet kitabı); 1996.
• 7.Ritwik P, Chrisentery-Singleton TE. Oral and dental considerations in pediatric cancers. Cancer Metastasis Rev. 2020;39:43-53.
• 8.Almendra Mattos RM, de Mendonca RMH, Dos Santos Aguiar S. Adherence to dental treatment reduces oral complications related to cancer treatment in pediatric and adolescent patients. Support Care Cancer. 2020;28:661-70.
• 9.Farsi DJ. Children Undergoing Chemotherapy: Is It Too Late for Dental Rehabilitation? J Clin Pediatr Dent. 2016;40:503-5.
• 10.Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J, et al. Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study. Lancet Oncol. 2014;15:35-47.
• 11.Erginel B, Vural S, Akin M, Karadag CA, Sever N, Yildiz A, et al. Wilms' tumor: a 24-year retrospective study from a single center. Pediatr Hematol Oncol. 2014;31:409-14.
• 12.King E. Oral sequelae and rehabilitation considerations for survivors of childhood cancer. Br Dent J. 2019;226:323-9.
• 13.Wani V, Kulkarni A, Pustake B, Takate V, Wani P, Sondhi JS. Prevalence, complications and dental management of the oral cancer in the pediatric patients. J Cancer Res Ther. 2018;14:1407-11.
• 14.Velten DB, Zandonade E, Monteiro de Barros Miotto MH. Prevalence of oral manifestations in children and adolescents with cancer submitted to chemotherapy. BMC Oral Health. 2017;17:49.
• 15.Berger Velten D, Zandonade E, Monteiro de Barros Miotto MH. Prevalence of oral manifestations in children and adolescents with cancer submitted to chemotherapy. BMC Oral Health. 2016;16:107.
• 16.Dreizen S, McCredie KB, Keating MJ, Bodey GP. Oral infections associated with chemotherapy in adults with acute leukemia. Postgrad Med. 1982;71:133-8, 43-6.
• 17.Dreizen S, McCredie KB, Keating MJ. Chemotherapy-associated oral hemorrhages in adults with acute leukemia. Oral Surg Oral Med Oral Pathol. 1984;57:494-8.
• 18.Fuchihata H, Furukawa S, Murakami S, Kubo K, Shimizutani K, Ikeda H, et al. Results of combined external irradiation and chemotherapy of bleomycin or peplomycin for squamous cell carcinomas of the lower gingiva. Int J Radiat Oncol Biol Phys. 1994;29:705-9.
• 19.Jaffe N, Toth BB, Hoar RE, Ried HL, Sullivan MP, McNeese MD. Dental and maxillofacial abnormalities in long-term survivors of childhood cancer: effects of treatment with chemotherapy and radiation to the head and neck. Pediatrics. 1984;73:816-23.
• 20.Dahllof G, Rozell B, Forsberg CM, Borgstrom B. Histologic changes in dental morphology induced by high dose chemotherapy and total body irradiation. Oral Surg Oral Med Oral Pathol. 1994;77:56-60.
• 21.Kaste SC, Hopkins KP, Bowman LC. Dental abnormalities in long-term survivors of head and neck rhabdomyosarcoma. Med Pediatr Oncol. 1995;25:96-101.
• 22.Rosenberg SW. Oral care of chemotherapy patients. Dent Clin North Am. 1990;34(2):239-50.
• 23.Dens F, Boute P, Vinckier F, Declerck D. Quantitative determination of immunologic components of salivary gland secretion in long-term, event-free pediatric oncology patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79:701-4.
• 24.Busenhart DM, Erb J, Rigakos G, Eliades T, Papageorgiou SN. Adverse effects of chemotherapy on the teeth and surrounding tissues of children with cancer: A systematic review with meta-analysis. Oral Oncol. 2018;83:64-72.
• 25.Nishimura S, Inada H, Sawa Y, Ishikawa H. Risk factors to cause tooth formation anomalies in chemotherapy of paediatric cancers. Eur J Cancer Care (Engl). 2013;22:353-60.